Skip to main content

Rezolute, Inc.

RZLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001509261

No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Rezolute, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Rezolute, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Rezolute, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Karnawat Sunil RatilalChief Commercial Officer69,275Sep 3, 20263
Roberts Brian KennethChief Medical Officer293,851Jul 7, 20264
Elam Nevan CCEO605,497Jul 7, 20264
Evans DaronCFO411,400Jul 7, 20265
Hogenhuis WladimirDirector119,675Dec 17, 20252
Labrucherie Gil MDirector55,500Nov 21, 20251
Kreher NerissaDirector58,576Nov 21, 20251
Kim Young-JinDirector170,950Nov 21, 20251
Harris ErikDirector21,000Nov 21, 20251
Fauchet PhilippeDirector55,500Nov 21, 20251
Handok, Inc.Director, 10% Owner5,942,617Mar 19, 20240
Genexine Inc.10% Owner91,300,933Jul 28, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 31, 2026 (view filing)Mar 301 dayEvans DaronCFOPPurchase+10.0K$2.85+$28.5K+2.5%414.5K after
Dec 17, 2025 (view filing)Dec 161 dayHogenhuis WladimirDirectorPPurchase+5.65K$1.69+$9.55K+5.0%119.7K after
Dec 17, 2025 (view filing)Dec 161 dayRoberts Brian KennethChief Medical OfficerPPurchase+28.0K$1.70+$47.6K+10.0%308.4K after
Dec 15, 2025 (view filing)Dec 15Same dayEvans DaronCFOPPurchase+40.0K$1.77+$70.8K+10.6%415.9K after
Dec 15, 2025 (view filing)Dec 15Same dayEvans DaronCFOPPurchase+5.00K$1.79+$8.95K+250.0%7.00K after2 lots
Dec 15, 2025 (view filing)Dec 15Same dayElam Nevan CCEOPPurchase+32.0K$1.59+$50.9K+5.3%641.1K after
Dec 15, 2025 (view filing)Dec 15Same dayKarnawat Sunil RatilalChief Commercial OfficerPPurchase+12.1K$1.62+$19.6K+20.4%71.5K after2 lots
Jun 26, 2025 (view filing)Jun 251 dayRoberts Brian KennethChief Medical OfficerPPurchase+2.50K$4.38+$10.9K+19.2%15.5K after
Jun 24, 2025 (view filing)Jun 24Same dayEvans DaronCFOPPurchase+5.00K$4.05+$20.3K+1.9%268.9K after
Jun 23, 2025 (view filing)Jun 1310 daysLateKim Young-JinDirectorPPurchase+1.23M$3.25+$4.00M+17.1%8.42M after
Jun 23, 2025 (view filing)Jun 1310 daysLateKreher NerissaDirectorPPurchase+3.08K$3.25+$10.0K+8.9%37.6K after
Apr 1, 2025 (view filing)Mar 311 dayHogenhuis WladimirDirectorPPurchase+6.76K$2.92+$19.7K+8.7%84.0K after
Mar 31, 2025 (view filing)Mar 274 daysElam Nevan CCEOPPurchase+12.3K$2.85+$35.1K+5.8%224.1K after
Mar 28, 2025 (view filing)Mar 262 daysEvans DaronCFOPPurchase+10.0K$2.89+$28.9K+4.4%237.9K after
Mar 28, 2025 (view filing)Mar 262 daysEvans DaronCFOPPurchase+10.0K$2.88+$28.8K+76.9%23.0K after
Feb 20, 2025 (view filing)Feb 182 daysHogenhuis WladimirDirectorPPurchase+10.0K$4.70+$47.0K+14.9%77.3K after
Feb 19, 2025 (view filing)Jun 25, 2024239 daysLateKim Young-JinDirectorPPurchase+1.25M$4.00+$5.00M+21.0%7.19M after
Dec 18, 2024 (view filing)Dec 18Same dayEvans DaronCFOPPurchase+10.0K$4.29+$42.9K+7.1%150.9K after
Dec 12, 2024 (view filing)Dec 12Same dayEvans DaronCFOPPurchase+9.00K$4.60+$41.4K+6.8%140.9K after
Dec 10, 2024 (view filing)––Evans DaronCFOPPurchase+10.5K$5.04+$53.2K+8.7%131.9K after
Sep 24, 2024 (view filing)Sep 24Same dayHogenhuis WladimirDirectorPPurchase+4.26K$4.70+$20.0K+11.4%41.8K after
Jun 27, 2024 (view filing)Jun 252 daysHogenhuis WladimirDirectorPPurchase+4.82K$4.15+$20.0K+14.7%37.5K after
Jun 14, 2024 (view filing)Jun 14Same dayRoberts Brian KennethChief Medical OfficerPPurchase+4.30K$3.91+$16.8K+8.6%54.4K after2 lots
Jun 14, 2024 (view filing)Jun 14Same dayRoberts Brian KennethChief Medical OfficerPPurchase+3.30K$3.92+$12.9KNew position1.38K after2 lots
Jun 14, 2024 (view filing)Jun 14Same dayEvans DaronCFOPPurchase+40.0K$4.04+$161.6KNew position40.0K after
May 31, 2024 (view filing)May 292 daysEvans DaronCFOPPurchase+451$3.50+$1.58K+0.4%121.4K after
May 28, 2024 (view filing)May 235 daysRoberts Brian KennethChief Medical OfficerPPurchase+7.50K$2.69+$20.2K+17.6%50.1K after2 lots
May 28, 2024 (view filing)May 23-245 daysEvans DaronCFOPPurchase+3.00K$3.22+$9.67K+30.0%13.0K after2 lots
Mar 29, 2024 (view filing)Mar 281 dayRoberts Brian KennethChief Medical OfficerPPurchase+500$2.55+$1.27K+86.8%1.08K after
Mar 19, 2024 (view filing)Oct 15, 2021-Jul 22, 2022886 daysLateHandok, Inc.Director, 10% OwnerPPurchase+3.93M$4.33+$17.0M+194.8%5.94M after2 lots
Mar 19, 2024 (view filing)Mar 154 daysEvans DaronCFOPPurchase+20.0K$1.69+$33.8KNew position20.0K after
Mar 18, 2024 (view filing)Mar 144 daysRoberts Brian KennethChief Medical OfficerPPurchase+10.0K$1.88+$18.8KNew position10.0K after
Mar 18, 2024 (view filing)Mar 711 daysRoberts Brian KennethChief Medical OfficerPPurchase+500$1.85+$925+657.9%576 afterAmended
Mar 14, 2024 (view filing)Jul 22, 2022-Mar 7, 2024601 daysLateKim Young-JinDirectorPPurchase+115.5K$3.20+$369.7KNew position115.5K after2 lots
Mar 8, 2024 (view filing)Mar 8Same dayEvans DaronCFOPPurchase+50.0K$1.93+$96.5K+70.5%120.9K after
Feb 28, 2024 (view filing)Feb 262 daysElam Nevan CCEOPPurchase+5.00K$1.68+$8.40K+177.5%7.82K after
Feb 27, 2024 (view filing)Feb 23-264 daysRoberts Brian KennethChief Medical OfficerPPurchase+8.00K$1.69+$13.5K+23.2%42.6K after2 lots
Feb 21, 2024 (view filing)Feb 165 daysRoberts Brian KennethChief Medical OfficerPPurchase+7.00K$1.31+$9.17K+25.4%34.6K after
Feb 20, 2024 (view filing)Feb 164 daysEvans DaronCFOPPurchase+41.9K$1.30+$54.5K+144.5%70.9K after
Feb 20, 2024 (view filing)Feb 164 daysEvans DaronCFOPPurchase+9.00K$1.37+$12.3KNew position4.50K after2 lots
Jul 6, 2023 (view filing)Jul 33 daysRoberts Brian KennethChief Medical OfficerPPurchase+5.00K$1.90+$9.50K+22.2%27.6K after
May 19, 2022 (view filing)May 17-192 daysRoberts Brian KennethSr VP, Clinic DevelopmentPPurchase+1.50K$3.24+$4.87K+7.1%22.6K after3 lots
May 9, 2022 (view filing)May 45 daysLabrucherie Gil MDirectorPPurchase+52.6K$3.80+$200.0K+5,593.1%53.6K afterAmended
May 6, 2022 (view filing)May 42 daysRoberts Brian KennethSr VP, Clinic DevelopmentPPurchase+21.1K$3.80+$80.0KNew position21.1K after
May 6, 2022 (view filing)Oct 15, 2021-May 4, 2022203 daysLateHogenhuis WladimirDirectorPPurchase+32.7K$4.44+$145.0KNew position32.7K after2 lots
Jul 28, 2021 (view filing)5:24 PM ETJul 23, 2019736 daysLateGenexine Inc.10% OwnerPPurchase+34.5M$0.29+$10.0M+60.7%91.3M after